Detroit Pistons star Cade Cunningham has suffered a collapsed lung and will miss at least two weeks with less than a month remaining in the NBA's regular season.
Detroit Pistons superstar Cade Cunningham has been diagnosed with a collapsed lung. Cunningham is expected to miss extended time due to the injury. Cunningham exited the Pistons victory over the Washington Wizards on Tuesday after playing just five minutes. Detroit said at the time that the All-Star guard was dealing with back spasms. The Pistons currently sit atop the Eastern Conference with a 3.5 game lead over the second-place Boston Celtics. Detroit is up four games in the loss column ove...
All-Star guard Cade Cunningham of the Eastern Conference-leading Detroit Pistons has a collapsed lung and is expected to miss at least two weeks and possibly more, a person with knowledge of the situation told The Associated Press on Thursday. The Pistons — who listed Cunningham as out for Thursday's game in Washington with a left back contusion — wouldn't start their playoff run until April 18 or 19. Cunningham got hurt in Tuesday's win over Washington, leaving midway through the opening qua...
The Detroit Pistons and Washington Wizards are set to go head-to-head on Thursday night. It was initially announced that Cade Cunningham was dealing with an injury and was listed on the injury report as a result. After initially being listed on the injury report with a back contusion, Shams Charania revealed that Cunningham is dealing […] The post Cade Cunningham’s collapsed lung will force him to miss ‘extended time’ as playoffs near appeared first on ClutchPoints .
An indefinite sideline stint for 24-year-old Cade Cunningham of the Detroit Pistons down the stretch of the 2025-26 NBA Regular Season The post Pistons star Cade Cunningham out indefinitely with collapsed lung appeared first on Eurohoops .
Publisher:EuroHoopsArticle published:
Keep up without checking every headline
Basketball digest. Email-only signup. Optional account for league choices.
Teams and players in this story
Open a profile to follow its coverage in your personal feed.
Comments